rutecarpine has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Han, M; Hu, L | 1 |
| Hao, Z; Liang, C; Sun, Y; Wang, C; Zhang, L; Zhou, J | 1 |
2 other study(ies) available for rutecarpine and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Rutaecarpine may improve neuronal injury, inhibits apoptosis, inflammation and oxidative stress by regulating the expression of ERK1/2 and Nrf2/HO-1 pathway in rats with cerebral ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Heme Oxygenase-1; Indole Alkaloids; Inflammation; Male; MAP Kinase Signaling System; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Quinazolines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK/p38 MAPK signaling pathway and interfering with the oxidative stress response.
Topics: Animals; Biomarkers; Biopsy; Blood Urea Nitrogen; Cytokines; Disease Models, Animal; Indole Alkaloids; Inflammation Mediators; Kidney Diseases; Kidney Function Tests; Male; MAP Kinase Signaling System; Oxidative Stress; Phosphorylation; Protective Agents; Quinazolines; Rats; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase | 2017 |